Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michi Egel-Mitani is active.

Publication


Featured researches published by Michi Egel-Mitani.


FEBS Letters | 1998

Purification and characterisation of a new hypothalamic satiety peptide, cocaine and amphetamine regulated transcript (CART), produced in yeast

Lars Thim; Per F. Nielsen; Martin Edward Judge; Asser Sloth Andersen; Ivan Diers; Michi Egel-Mitani; Sven Hastrup

Cocaine and amphetamine regulated transcript (CART) is a newly discovered hypothalamic peptide with a potent appetite suppressing activity following intracerebroventricular administration. When the mature rat CART sequence encoding CART(1–102) was inserted in the yeast expression plasmid three CART peptides could be purified from the fermentation broth reflecting processing at dibasic sequences. None of these corresponded to the naturally occurring CART(55–102). In order to obtain CART(55–102) the precursor Glu‐Glu‐Ile‐Asp‐CART(55–102) has been produced and CART(55–102) was generated by digestion of the precursor with dipeptidylaminopeptidase‐1. All four generated CART peptides have been characterised by N‐terminal amino acid sequencing and mass spectrometry. The CART peptides contain six cysteine residues and using the yeast expressed CART(62–102) the disulphide bond configuration was found to be I–III, II–V and IV–VI. When the four CART peptides were intracerebroventricularly injected in fasted mice (0.1 to 2.0 μg) they all produced a dose dependent inhibition of food intake.


Gene | 1996

A removable spacer peptide in an α-factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae

Thomas Børglum Kjeldsen; Jakob Brandt; Asser Sloth Andersen; Michi Egel-Mitani; Morten Hach; Annette Frost Pettersson; Knud Vad

An alpha-factor leader/insulin precursor fusion protein was produced in Saccharomyces cerevisiae and metabolically labeled in order to analyse the efficiency of maturation and secretion. A substantial fraction of the secreted material was found in a hyperglycosylated unprocessed form, indicating incomplete Kex2p endopeptidase maturation. Introduction of a spacer peptide (EAEAEAK) after the dibasic Kex2p site, creating a N-terminal extension of the insulin precursor, greatly increased the Kex2p catalytic efficiency and the fermentation yield of insulin precursor. The N-terminal extension features a Lys to allow subsequent proteolytic removal by trypsin or the Achromobacter lyticus Lys-specific protease. Dipeptidyl aminopeptidase A (DPAPA) activity removing Glu-Ala dipeptides from the extension was inhibited by adding a Glu N-terminally to the extension. Unexpectedly, this modified N-terminal extension (EEAEAEAK) was partially cleaved after the Lys during fermentation. This monobasic proteolytic activity was demonstrated to be associated with Yap3p. Yap3p cleavage could be prevented by insertion of a Pro before the Lys (EEAEAEAPK).


Enzyme and Microbial Technology | 2000

Yield improvement of heterologous peptides expressed in yps1-disrupted Saccharomyces cerevisiae strains.

Michi Egel-Mitani; Asser Sloth Andersen; Ivan Diers; Morten Hach; Lars Thim; Sven Hastrup; Knud Vad

Heterologous protein expression levels in Saccharomyces cerevisiae fermentations are highly dependent on the susceptibility to endogenous yeast proteases. Small peptides, such as glucagon and glucagon-like-peptides (GLP-1 and GLP-2), featuring an open structure are particularly accessible for proteolytic degradation during fermentation. Therefore, homogeneous products cannot be obtained. The most sensitive residues are found at basic amino acid residues in the peptide sequence. These heterologous peptides are degraded mainly by the YPS1-encoded aspartic protease, yapsin1, when produced in the yeast. In this article, distinct degradation products were analyzed by HPLC and mass spectrometry, and high yield of the heterologous peptide production has been achieved by the disruption of the YPS1 gene (previously called YAP3). By this technique, high yield continuous fermentation of glucagon in S. cerevisiae is now possible.


Gene | 1988

Competitive expression of two heterologous genes inserted into one plasmid in Saccharomyces cerevisiae

Michi Egel-Mitani; Mogens Trier Hansen; Kjeld Norris; Leo Snel; Niels Fiil

Plasmids were constructed which contained two expression units encoding single-chain insulin precursors. Surprisingly, the total amount of insulin precursor produced was similar to that produced from plasmids containing a single expression unit. In this system, therefore, two expression cassettes can be brought to compete for the limited ability of the yeast cell for synthesis and secretion. Using genes encoding B(1-29)-A(1-21) and B(1-29)-Ala-Ala-Lys-A-(1-21), the slightly different precursors could be quantified individually after separation by high-performance liquid chromatography from the culture supernatant. The two-cassette system allowed a sensitive and well controlled comparison of parameters important for optimal expression of a heterologous gene in Saccharomyces cerevisiae. The system was used to compare two promoter constructions and also to evaluate the position of expression cassettes in the plasmid. Finally the codon usage in the gene to be expressed was found to influence its ability to compete for expression.


Archive | 1993

C. antarctica lipase and lipase variants

Allan Svendsen; Shamkant Anant Pathar; Michi Egel-Mitani; Kim Borch; Ib Groth Clausen; Mogens Trier Hansen


Yeast | 1990

A novel aspartyl protease allowing KEX2-independent MFα propheromone processing in yeast

Michi Egel-Mitani; Hanne Pia Flygenring; Mogens Trier Hansen


Archive | 1997

Method for the production of polypeptides

Michi Egel-Mitani; Jakob Brandt; Knud Vad


Archive | 1993

C. antarctica lipase variants

Allan Svendsen; Shamkant Anant Pathar; Michi Egel-Mitani; Kim Borch; Ib Groth Clausen; Mogens Trier Hansen


Nucleic Acids Research | 1987

Nucleotide sequence of the gene encoding the Saccharomyces kluyveri α mating pheromone

Michi Egel-Mitani; Mogens Trier Hansen


Archive | 1997

Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides

Michi Egel-Mitani; Jakob Brandt; Knud Vad

Collaboration


Dive into the Michi Egel-Mitani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge